Based on little changes in the amounts of Bcl-2 and Bax in the cytoplasm of AD and control specimens, this mechanism, through altering the Bax/Bcl-2 ratio, is unlikely to be the source of apoptosis in this in vivo study of AD. The gene discussed is BCL2; the disease is Alzheimer disease.